Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRUE
3926
DELISTED
TrueCar
TRUE
| $326K | ﹤0.01% |
171,521
+47,834
| +39% | +$73K |
|
|
CYBR
3927
PUT
DELISTED
CyberArk
CYBR
| $326K | ﹤0.01% |
+800
| New | +$292K |
|
3928
Hawthorn Bancshares
HWBK
$277M
| $325K | ﹤0.01% |
11,166
+10,762
| +2,664% | +$310K |
|
|
FRGE
3929
DELISTED
Forge Global Holdings
FRGE
| $325K | ﹤0.01% |
17,051
+9,160
| +116% | +$126K |
|
|
NOA
3930
North American Construction
NOA
$389M
| $324K | ﹤0.01% |
20,306
-197
| -1% | -$3.21K |
|
|
NREF
3931
NexPoint Real Estate Finance
NREF
$318M
| $324K | ﹤0.01% |
23,499
+4,240
| +22% | +$60.7K |
|
3932
NewAmsterdam Pharma
NAMS
$3.19B
| $324K | ﹤0.01% |
17,871
+1,986
| +13% | +$36.2K |
|
3933
Amplify Junior Silver Miners ETF
SILJ
$3.89B
| $324K | ﹤0.01% |
+21,863
| New | +$284K |
|
3934
Hagerty
HGTY
$1.32B
| $321K | ﹤0.01% |
31,793
-88
| -0.3% | -$820 |
|
|
SEVN
3935
Seven Hills Realty Trust
SEVN
$175M
| $321K | ﹤0.01% |
26,582
+11,543
| +77% | +$136K |
|
|
NB
3936
NioCorp Developments
NB
$745M
| $321K | ﹤0.01% |
137,672
+90,923
| +194% | +$227K |
|
|
EWCZ
3937
DELISTED
European Wax Center
EWCZ
| $320K | ﹤0.01% |
56,869
+17,618
| +45% | +$80K |
|
3938
RGC Resources
RGCO
$226M
| $319K | ﹤0.01% |
14,241
+5,901
| +71% | +$125K |
|
3939
Cartesian Therapeutics
RNAC
$264M
| $319K | ﹤0.01% |
30,675
+16,306
| +113% | +$174K |
|
3940
Companhia Siderúrgica Nacional
SID
$1.19B
| $318K | ﹤0.01% |
227,158
+107,752
| +90% | +$167K |
|
|
TTSH
3941
DELISTED
Tile Shop Holdings
TTSH
| $318K | ﹤0.01% |
49,963
+19,360
| +63% | +$116K |
|
3942
PUT
ImmunityBio
IBRX
$8.11B
| $317K | ﹤0.01% |
+120,000
| New | +$323K |
|
3943
OmniAb
OABI
$499M
| $316K | ﹤0.01% |
181,677
+76,064
| +72% | +$127K |
|
|
TGB
3944
Trekor Metals
TGB
$3.08B
| $316K | ﹤0.01% |
100,181
+36,685
| +58% | +$85.8K |
|
3945
CALL
Yeti Holdings
YETI
$3.44B
| $315K | ﹤0.01% |
10,000
| – | – |
|
3946
Benitec Biopharma
BNTC
$431M
| $315K | ﹤0.01% |
+26,940
| New | +$377K |
|
3947
CuriosityStream
CURI
$237M
| $314K | ﹤0.01% |
55,768
+55,180
| +9,384% | +$253K |
|
3948
Alico
ALCO
$304M
| $314K | ﹤0.01% |
9,603
+2,413
| +34% | +$73.2K |
|
3949
Rimini Street
RMNI
$470M
| $314K | ﹤0.01% |
83,217
+29,421
| +55% | +$98.3K |
|
3950
Utah Medical Products
UTMD
$230M
| $312K | ﹤0.01% |
5,483
+2,136
| +64% | +$116K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.